Topic Archives: Weiss Research

Has anyone tried the WEISS ULTIMATE PORTFOLIO which claims to beat the NASDAQ by a factor of 2 and with less risk than is involved in buying Amazon etc? Five years for $1997. Does anyone know if its track record supports its claims? Its method sounds good – buy the top 10 stocks out of […]

Monthly stock-picking service that focuses on finding oil and energy “penny stocks”, often microcaps listed in Canada. First noticed in Summer 2017, this Weiss-published letter seems to be a continuation or replacement of Chuck de Castro’s previous self-published and long-running letter called Penny Oil Speculator.

High cost small-cap newsletter that looks for “explosive profit potential.” Currently edited by Grant Wasylik, who had recommended “safe” investments in previous work at Palm Beach Letter and also helms Wall Street Front Runner for Weiss. Adventure Capitalist was previously edited by Frank Curzio, who moved on to launch is own publishing firm.

The Disruptors and Dominators newsletter, one of the “entry level” letters from Weiss, is out pitching a “silver bullet” company — a firm that has developed a universal cancer vaccine. And, of course, they’ll tell you all about it — for your $49 subscription fee. Here at Stock Gumshoe, we’d like you to think things […]

“WHY DIE? “This virtually unknown company is trying to “turn off” heart attacks and cancer before they happen! “It possesses the secret that could END crippling and chronic diseases like arthritis, diabetes, hepatitis, AIDS and more — AT WILL! “Buy this stock NOW to go for truly explosive profits in medicine’s all new ‘golden age!’” […]

More “Contrarian Bonanza” picks, you ask? Well of course! There are several new teaser ads stacking up in the Thinkolator’s inbox, but before we get to those … let’s close the book on the “contrarian bonanza” picks from the Weiss folks as they tease their Million-Dollar Contrarian Portfolio. There are three left of the seven […]

It’s a long list of teasers that tempts us into the Weiss fold, enticing us to subscribe to his real-money Million-Dollar Contrarian Portfolio. Tempted to subscribe? No, not the mighty Gumshoe! Tempted to sniff out the answers for free? You bet! The first teaser picks from this ad inspired a bit of debate (though, to […]

Comments

No comments.

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch